Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články
PubMed
31197325
PubMed Central
PMC6736134
DOI
10.1093/ndt/gfz089
PII: 5512198
Knihovny.cz E-zdroje
- Klíčová slova
- acute kidney injury, big data, cohorts, guidelines, registry,
- MeSH
- biomedicínský výzkum normy MeSH
- dialýza ledvin normy MeSH
- dítě MeSH
- dospělí MeSH
- kooperační chování * MeSH
- lidé MeSH
- nefrologie organizace a řízení MeSH
- registrace MeSH
- společnosti lékařské * MeSH
- transplantace ledvin normy MeSH
- veřejná politika * MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
The strengths and the limitations of research activities currently present in Europe are explored in order to outline how to proceed in the near future. Epidemiological and clinical research and public policy in Europe are generally considered to be comprehensive and successful, and the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) is playing a key role in the field of nephrology research. The Nephrology and Public Policy Committee (NPPC) aims to improve the current situation and translation into public policy by planning eight research topics to be supported in the coming 5 years by ERA-EDTA.
1st Department of Internal Medicine 3rd Faculty of Medicine Charles University Prague Czech Republic
Abdominal Center Nephrology University of Helsinki and Helsinki University Hospital Helsinki Finland
CNR IFC Ospedali Riuniti Reggio Calabria Italy
Consultant Senior Lecturer Population Health Sciences University of Bristol UK
Departament of Medicine Universitat Autònoma de Barcelona Barcelona Spain
Department of Medicine Division of Nephrology University Hospital Wuerzburg Germany
Department of Nephrology University Hospital of Patras Patras Greece
Department of Nephrology University Medical Center Utrecht The Netherlands
Department of Nephrology Vall d'Hebron University Hospital Barcelona Spain
European Renal Best Practice London UK
Finnish Registry for Kidney Diseases Helsinki Finland
Glasgow Renal and Transplant Unit Queen Elizabeth University Hospital Glasgow UK
Zobrazit více v PubMed
Zoccali C, Arici M, Blankestijn PJ. et al. The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council. Nephrol Dial Transplant 2018; 33: 1077–1082 PubMed
Schaeffner ES, van der Giet M, Gaedeke J. et al. The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol 2010; 25: 203–210 PubMed
Raum E, Rothenbacher D, Low M. et al. Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil 2007; 14: 809–814 PubMed
Cirillo M, Terradura-Vagnarelli O, Mancini M. et al. Cohort profile: The Gubbio Population Study. Int J Epidemiol 2014; 43: 713–720 PubMed PMC
Diercks GF, Janssen WM, van Boven AJ. et al. Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]). Am J Cardiol 2000; 86: 635–638 PubMed
McIntyre NJ, Fluck RJ, McIntyre CW. et al. Risk profile in chronic kidney disease stage 3: older versus younger patients. Nephron Clin Pract 2011; 119: c269–c276 PubMed
Dunder K, Lind L, Zethelius B. et al. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM). Am Heart J 2004; 148: 596–601 PubMed
Seiler S, Rogacev KS, Roth HJ. et al. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol 2014; 9: 1049–1058 PubMed PMC
Landray MJ, Thambyrajah J, McGlynn FJ. et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001; 38: 537–546 PubMed
van Zuilen AD, van der Tweel I, Blankestijn PJ. et al. Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232]. Trials 2006; 7: 8. PubMed PMC
Marks A, Fluck N, Prescott GJ. et al. Definitions of progression in chronic kidney disease–predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up. Nephrol Dial Transplant 2014; 29: 333–341 PubMed
Kronenberg F, Kuen E, Ritz E. et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11: 105–115 PubMed
Moranne O, Froissart M, Rossert J. et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009; 20: 164–171 PubMed PMC
Jager KJ, Ocak G, Drechsler C. et al. The EQUAL study: a European study in chronic kidney disease stage 4 patients. Nephrol Dial Transplant 2012; 27 (Suppl 3): iii27–iii31 PubMed
Eckardt KU, Barthlein B, Baid-Agrawal S. et al. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant 2012; 27: 1454–1460 PubMed
Hoefield RA, Kalra PA, Baker P. et al. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis 2010; 56: 1072–1081 PubMed
Stengel B, Combe C, Jacquelinet C. et al. The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study. Nephrol Dial Transplant 2014; 29: 1500–1507 PubMed PMC
Martinez-Castelao A, Gorriz JL, Portoles JM. et al. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol 2011; 12: 53. PubMed PMC
Navis GJ, Blankestijn PJ, Deegens J. et al. The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands. Nephrol Dial Transplant 2014; 29: 1145–1150 PubMed
Schaefer F, Doyon A, Azukaitis K. et al. Cardiovascular phenotypes in children with CKD: the 4C study. Clin J Am Soc Nephrol 2017; 12: 19–28 PubMed PMC
Nisula S, Kaukonen KM, Vaara ST. et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 2013; 39: 420–428 PubMed
Geri G, Stengel B, Jacquelinet C. et al. Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study. Ann Intensive Care 2018; 8: 77. PubMed PMC
Collaborative ST. Outcomes After Kidney injury in Surgery (OAKS): protocol for a multicentre, observational cohort study of acute kidney injury following major gastrointestinal and liver surgery. BMJ Open 2016; 6: e009812 PubMed PMC
Rondeau E, Faguer S, Robert T.. Advocacy for a European network of renal intensive care units. Nephrol Dial Transplant 2019; doi: 10.1093/ndt/gfy398 PubMed
Mehta RL, Cerdá J, Burdmann EA. et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 2015; 385: 2616–2643 PubMed
Helve J, Kramer A, Abad-Diez JM. et al. Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2018; 33: 1428–1435 PubMed
Ceretta ML, Noordzij M, Luxardo R. et al. Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry. Nephrol Dial Transplant 2018; 33: 1794–1804 PubMed
Li G, Sajobi TT, Menon BK. et al. Registry-based randomized controlled trials – what are the advantages, challenges, and areas for future research? J Clin Epidemiol 2016; 80: 16–24 PubMed
Fröberg O, Lagerqvist B, Olivecrona G. et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013; 369: 1587–1597 PubMed
Wingen AM, Fabian-Bach C, Schaefer F. et al.; European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 1997; 349: 1117–1123 PubMed
ESCAPE Trial Group, Wühl E, Trivelli A, Picca S. et al.Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639–1650 PubMed
van den Belt SM, Heerspink HJL, Gracchi V. et al.; ESCAPE Trial Group. Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol 2018; 29: 2225–2233 PubMed PMC
Harambat J, Kunzmann K, Azukaitis K. et al. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease. Kidney Int 2017; 92: 1507–1514 PubMed
Shroff R, Bayazit A, Stefanidis CJ. et al. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study. BMC Nephrol 2018; 19: 199. PubMed PMC
Harambat J, Bonthuis M, Groothoff JW. et al. Lessons learned from the ESPN/ERA-EDTA Registry. Pediatr Nephrol 2016; 31: 2055–2064 PubMed
Chesnaye NC, Schaefer F, Groothoff JW. et al. Mortality risk in European children with end-stage renal disease on dialysis. Kidney Int 2016; 89: 1355–1362 PubMed
van Stralen KJ, Borzych-Dużalka D, Hataya H. et al. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 2014; 86: 168–174 PubMed
Höcker B, Schneble L, Murer L. et al. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN Registry study. Transplantation 2018; doi: 10.1097/TP.0000000000002414 PubMed
Shroff R, Stefanidis CJ, Askiti V. et al. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant 2013; 28: 1908–1914 PubMed
Rees L, Azocar M, Borzych D. et al. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol 2011; 22: 2303–2312 PubMed PMC
Ashton EJ, Legrand A, Benoit V. et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies. Kidney Int 2018; 93: 961–967 PubMed
Trautmann A, Schnaidt S, Lipska-Ziętkiewicz BS. et al. Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 2017; 28: 3055–3065 PubMed PMC
Mandrile G, van Woerden CS, Berchialla P. et al. Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type. Kidney Int 2014; 86: 1197–1204 PubMed
Ebner K, Feldkoetter M, Ariceta G. et al. Rationale, design and objectives of ARegPKD, a European ARPKD registry study. BMC Nephrol 2015; 16: 22. PubMed PMC
Nagler EV, Webster AC, Bolignano D. et al. European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant 2014; 29: 731–738 PubMed
Van der Veer SN, Haller MC, Pittens C. et al. Setting priorities for optimizing vascular access decision making – an international survey of patients and clinicians. PLoS ONE 2015; 10: e0128228. PubMed PMC
Tong A, Craig JC, Nagler EV. et al.; for the SONG Executive Committee and the European Renal Best Practice Advisory Board, SONG Executive Committee. Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative. Nephrol Dial Transplant 2017; 32: 1963–1966 PubMed
Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. https://training.cochrane.org/handbook (19 April 2019, date last accessed)
Spasovski G, Vanholder R, Allolio B. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014; 170: G1–47 PubMed
Van der Veer S, Tomson CRV, Jager KJ. et al. Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines. Nephrol Dial Transplant 2014; 29: 951–957 PubMed
Van der Veer SN, Van Biesen W, Couchoud C. et al. Measuring the quality of renal care: things to keep in mind when selecting and using quality indicators. Nephrol Dial Transplant 2014; 29: 1460–1467 PubMed
Liabeuf S, Van Stralen KJ, Caskey F. et al. Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country’s healthcare expenditure and nephrologist workforce? Nephrol Dial Transplant 2017; 32: 1737–1749 PubMed PMC
Jager KJ, Zoccali C.. QUality European STudies (QUEST)–a step forward in the quality of RRT care. Nephrol Dial Transplant 2005; 20: 2005–2006 PubMed
Pippias M, Jager KJ, Kramer A. et al. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2016; 31: 831–841 PubMed
Vanholder R, Annemans L, Brown E. et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 2017; 13: 393–409 PubMed
Kerr M, Bray B, Medcalf J. et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 2012; 27: iii73–iii80 PubMed PMC
Van Biesen W, van der Veer SN, Murphey M. et al. Patients’ perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients' Federation on information and support on renal replacement therapy. PLoS ONE 2014; 9: e103914. PubMed PMC
Jager KJ, Stel VS, Branger P. et al. The effect of differing kidney disease treatment modalities and organ donation and transplantation practices on health expenditure and patient outcomes. Nephrol Dial Transplant 2018; 33: 560–562 PubMed
Vanholder R, Stel VS, Jager KJ. et al. How to increase kidney transplant activity throughout Europe - an advocacy review by the European Kidney Health Alliance. Nephrol Dial Transplant 2019; doi: 10.1093/ndt/gfy390 PubMed
Maini R, Wong DB, Addison D. et al. Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era. J Am Soc Nephrol 2018; 29: 2782–2786 PubMed PMC
Vanholder R, Van Laecke S, Glorieux G. et al. Deleting death and dialysis: conservative care of cardio-vascular risk and kidney function loss in chronic kidney disease (CKD). Toxins 2018; 10: pii: E237 PubMed PMC
Taylor DM, Fraser SDS, Bradley JA. et al. A systematic review of the prevalence and associations of limited health literacy in CKD. Clin J Am Soc Nephrol 2017; 12: 1070–1084 PubMed PMC
van Gelder MK, Mihaila SM, Jansen J. et al. From portable dialysis to a bioengineered kidney. Expert Rev Med Devices 2018; 15: 323–336 PubMed
Kramer A, Pippias M, Noordzij M. et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary. Clin Kidney J 2018; 11: 108–122 PubMed PMC
Süleymanlar G, Utaş C, Arinsoy T. et al. A population-based survey of Chronic REnal Disease In Turkey–the CREDIT study. Nephrol Dial Transplant 2011; 26: 1862–1871 PubMed PMC